Back to today’s briefing

Story perspectives

Revolutionary GARD Method Offers Hope for HPV Throat Cancer

9/30/2025

44 5

Summary

Story summary

Cleveland Clinic researchers identify HPV-positive throat cancer patients who may benefit from lower radiation doses using Genomic Adjusted Radiation Dose (GARD).
GARD personalizes radiation by tailoring dose to tumor genomics.
Analysis of 191 patients shows GARD scores correlate with better survival.
Dr. Torres-Roca and colleagues advocate integrating genomics into radiation oncology and guiding trials on selecting patients for reduced doses.

1 of 1

Story summary

Cleveland Clinic researchers identify HPV-positive throat cancer patients who may benefit from lower radiation doses using Genomic Adjusted Radiation Dose (GARD).
GARD personalizes radiation by tailoring dose to tumor genomics.
Analysis of 191 patients shows GARD scores correlate with better survival.
Dr. Torres-Roca and colleagues advocate integrating genomics into radiation oncology and guiding trials on selecting patients for reduced doses.